Piper Sandler Maintains Neutral on Viatris, Raises Price Target to $14
Benzinga Newsdesk 6 days ago
Analyst RatingsNewsPrice Target
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $13 to $14.
Piper Sandler analyst David Amsellem maintains Viatris (NASDAQ:VTRS) with a Neutral and raises the price target from $13 to $14.